Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
How Trump's marijuana executive order could change medical research landscape - 2The most effective method to Pick The Right Speakers
- 3Artemis II astronauts will see parts of the moon no human has before. Here’s how
- 4NASA's SPHEREx telescope completes its 1st cosmic map of the entire sky and it's stunning!
- 5Europe’s EV Boom Was Real in 2025. The Real Fight Starts In 2026
- We may have one thing in common with jellyfish, new research finds
- Witness the elegance of the cosmic butterfly in a remarkable telescope photo
- How to identify animal tracks, burrows and other signs of wildlife in your neighborhood
- Thousands of Walgreens nasal spray bottles recalled. See which ones.
- NASA set to launch Artemis 2 moon mission today, the 1st crewed lunar flight since 1972
- It May Take a Year to Restore Abu Dhabi Aluminum Output, EGA Says
- The 15 Most Powerful Forerunners in Business
- Figure out How to Streamline Eco-friendliness in Your Volvo XC40
- Figure out How to Pick the Right Toothbrush for You
